Alliance Pharma PLC Director Dealings (6200K)

TIDMAPH

RNS Number : 6200K

Alliance Pharma PLC

23 September 2016

 
 For immediate release   23 September 2016 
 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Director Dealings

Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, was notified on 22 September 2016 that, on the same day, John Dawson, Chief Executive Officer of the Company, sold 3,000,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 45.25 pence per share.

Following this transaction, Mr Dawson's total beneficial interest in the Company is 56,576,402 Ordinary Shares, representing approximately 12.0% of the Company's issued share capital.

For further information:

 
 Alliance Pharma plc                             + 44 (0) 1249 466966 
 John Dawson, Chief Executive 
  Officer 
  Andrew Franklin, Chief Financial 
  Officer 
 Sarah Robinson, Company Secretary 
 www.alliancepharma.co.uk 
                                                     + 44 (0) 20 7466 
 Buchanan                                                        5000 
 Mark Court / Sophie Cowles 
  / Jane Glover 
 
                                                     + 44 (0) 20 7260 
 Numis Securities Limited                                        1000 
 Nominated Adviser: Michael 
  Meade / Freddie Barnfield 
 Corporate Broking: James 
  Black / Toby Adcock 
 

Notes to editors:

About Alliance Pharma

Alliance, founded in 1998, is an international speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has sales in more than 100 countries worldwide via direct sales, joint ventures and a network of distributors. Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Company continues to explore opportunities to expand its product portfolio.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

ANNEX

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ------------------------------------------------------ 
 a)   Name                       John Dawson 
---  -------------------------  --------------------------- 
 2    Reason for the notification 
---  ------------------------------------------------------ 
 a)   Position/status            Chief Executive Officer 
---  -------------------------  --------------------------- 
 b)   Initial notification       Initial 
       /Amendment 
---  -------------------------  --------------------------- 
 3    Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------ 
 a)   Name                       Alliance Pharma plc 
---  -------------------------  --------------------------- 
 b)   LEI                        n/a 
---  -------------------------  --------------------------- 
 4    Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------ 
 a)   Description of             1p ordinary shares 
       the financial 
       instrument, type           ISIN: GB0031030819 
       of instrument 
 
       Identification 
       code 
---  -------------------------  --------------------------- 
 b)   Nature of the              Sale 
       transaction 
---  -------------------------  --------------------------- 
 c)   Price(s) and volume(s)      Price(s)   Volume(s) 
                                  ---------  ---------- 
                                   45.25      3,000,000 
                                  ---------  ---------- 
---  -------------------------  --------------------------- 
 d)   Aggregated information     Total of 3,000,000 shares 
                                  at 45.25p 
 
       - Aggregated volume 
 
 
       - Price 
---  -------------------------  --------------------------- 
 e)   Date of the transaction    22 September 2016 
---  -------------------------  --------------------------- 
 f)   Place of the transaction   London Stock Exchange, AIM 
---  -------------------------  --------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHDDGDCRBDBGLD

(END) Dow Jones Newswires

September 23, 2016 02:00 ET (06:00 GMT)